Ryszard Kole
Nessuna posizione attualmente
Profilo
Ryszard Kole worked as the Senior Vice President-Discovery Research at Sarepta Therapeutics, Inc. Prior to that, he was the President & Chief Scientific Officer at Ercole Biotech, Inc. He also worked as a Professor-Pharmacology Department at The University of North Carolina at Charlotte.
Kole holds a doctorate degree from the Polish Academy of Sciences.
Precedenti posizioni note di Ryszard Kole
| Società | Posizione | Fine |
|---|---|---|
Ercole Biotech, Inc.
 Ercole Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sarepta Therapeutics, Inc., Ercole Biotech, Inc. develops splice switching drugs for the treatment of major human diseases. The company is based in Research Triangle Park, NC. The company was founded by Jorn Gorlach. Ercole Biotech was acquired by Sarepta Therapeutics, Inc. on March 20, 2008 for $8.25 million. | Presidente | - |
| The University of North Carolina at Charlotte | Corporate Officer/Principal | - |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formazione di Ryszard Kole
| Polish Academy of Sciences | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Ercole Biotech, Inc.
Ercole Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sarepta Therapeutics, Inc., Ercole Biotech, Inc. develops splice switching drugs for the treatment of major human diseases. The company is based in Research Triangle Park, NC. The company was founded by Jorn Gorlach. Ercole Biotech was acquired by Sarepta Therapeutics, Inc. on March 20, 2008 for $8.25 million. | Commercial Services |
- Borsa valori
- Insiders
- Ryszard Kole
